Clinical Trial

Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects.

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-center, nonrandomized, and open design study to investigate the pharmacokinetics, mass balance, metabolism and excretion of HSK31858 in healthy male subjects.
Trial Details
NCT Number NCT06569784
Lead Sponsor Xizang Haisco Pharmaceutical Co., Ltd
Conditions Healthy
Enrollment 6 participants
Start Date 2024-05-30
Primary Completion 2024-07-02 (estimated)
Study Completion 2024-10-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-26